Open AccessTocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
Author(s) -
Ahmed Mady,
Waleed Aletreby,
Basheer Abdulrahman,
Mohammed Lhmdi,
Alfateh Noor,
Saleh A. Alqahtani,
Ibrahim Soliman,
Abdulrahman Alharthy,
Dimitrios Karakitsos,
Ziad A. Memish
Publication year - 2020
Publication title -
annals of medicine and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 23
ISSN - 2049-0801
DOI - 10.1016/j.amsu.2020.10.061
Subject(s) - medicine , tocilizumab , interquartile range , mechanical ventilation , pneumonia , intensive care unit , retrospective cohort study , oxygen therapy , mortality rate , rheumatoid arthritis
COVID-19 associated critical illness characterized by rapidly evolving acute respiratory failure (ARF) can develop, especially on the grounds of hyperinflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom